TipRanks
Fusion Antibodies Plc (GB:FAB)
LSE:FAB
UK Market
Want to see GB:FAB full AI Analyst Report?

Fusion Antibodies Plc (FAB) Financial Statements

10 Followers

Fusion Antibodies Plc Financial Overview

Fusion Antibodies Plc's market cap is currently £7.51M. The company's EPS TTM is p-0.0099; its P/E ratio is -6.06; Fusion Antibodies Plc is scheduled to report earnings on September 14, 2026, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue£ 2.11M£ 1.97M£ 1.14M£ 2.90M£ 4.80M
Gross Profit£ 1.10M£ 430.00K£ -265.00K£ 202.00K£ 1.72M
Operating Income£ -1.98M£ -1.78M£ -2.29M£ -2.83M£ -1.33M
EBITDA£ -1.85M£ -1.62M£ -2.06M£ -2.48M£ -573.00K
Net Income£ -1.15M£ -1.71M£ -2.23M£ -2.60M£ -1.20M
Balance Sheet
Cash & Short-Term Investments£ 1.04M£ 359.00K£ 1.20M£ 195.00K£ 2.05M
Total Assets£ 2.73M£ 1.32M£ 2.42M£ 2.06M£ 4.92M
Total Debt£ 331.00K£ 20.00K£ 43.00K£ 75.00K£ 69.00K
Net Debt£ -712.00K£ -339.00K£ -1.16M£ -120.00K£ -1.98M
Total Liabilities£ 1.10M£ 654.00K£ 627.00K£ 939.00K£ 1.23M
Stockholders' Equity£ 1.62M£ 669.00K£ 1.79M£ 1.12M£ 3.68M
Cash Flow
Free Cash Flow£ -1.17M£ -1.37M£ -1.77M£ -1.87M£ -591.00K
Operating Cash Flow£ -1.11M£ -1.36M£ -1.77M£ -1.75M£ -333.00K
Investing Cash Flow£ -60.00K£ -5.00K£ 1.00K£ -114.00K£ -258.00K
Financing Cash Flow£ 1.85M£ 529.00K£ 2.77M£ 7.00K£ -46.00K
Currency in GBP

Fusion Antibodies Plc Earnings and Revenue History

Fusion Antibodies Plc Debt to Assets

Fusion Antibodies Plc Cash Flow

Fusion Antibodies Plc Forecast EPS vs Actual EPS